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Mycobacterium 
heckeshornense 
Infection in 
HIV-infected 
Patient
To the Editor:  Mycobacterium 
heckeshornense is a slow-growing 
scotochromogen phenotypically and 
phylogenetically related to M. xenopi. 
It was ﬁ  rst identiﬁ  ed as a cause of lung 
infection on the basis of unique 16s 
rRNA and 16S–23S spacer sequenc-
ing (1). Published data are limited to 
the original description and 5 case 
reports in English-language literature 
(2–5). We report disseminated M. 
heckeshornense infection in an HIV-
infected patient and document its role 
as an emerging pathogen.
A man 40 years of age with dif-
fuse large B-cell lymphoma had ad-
vanced HIV infection and a CD4 count 
<10 cells/mm3. Antiretroviral therapy 
(ART) comprising abacavir/lamivu-
dine and lopinavir/ritonavir was initi-
ated. Ongoing night sweats and weight 
loss after chemotherapy prompted 
submission of blood cultures, which 
were positive for M. heckeshornense 
after 41 days’ incubation.
Progressive wasting after 2 
months’ ART prompted treatment for 
M. heckeshornense with isoniazid 
300 mg 1x/d, clarithromycin 500 mg 
2×/d, moxiﬂ  oxacin 400 mg 1×/d, vi-
tamin B6 25 mg 1×/d, and rifabutin 
150 mg 3×/wk. Pretreatment blood 
and urine cultures grew M. hecke-
shornense after 41 and 30 days’ incu-
bation, respectively. After 18 months 
of ART and antimycobacterial thera-
py, the patient’s condition improved, 
and his mycobacterial blood culture 
remained negative.
Blood for cultures was collected 
in Vacutainers (Becton Dickinson, 
Sparks, MD, USA), injected into 
Myco-F lytic media (Becton Dickin-
son), and incubated at 35–37°C in a 
fully automated BACTEC 9000 MB 
(Becton Dickinson) blood culture 
instrument for 42 days. Ziehl-Neels-
en stain conﬁ  rmed  acid-fast  bacilli 
(AFB) after 41 days. Gen-Probe Ac-
cuProbe DNA probes (Gen-Probe 
Incorporated, San Diego, CA, USA) 
for  M. avium and M. tuberculosis 
complexes were negative. The ini-
tial blood culture was subcultured to 
Middlebrook 7H11 media and incu-
bated at 35°–37°C, demonstrating a 
growth range of 37°–45°C (optimal 
growth at 42°–45°C). The isolate was 
forwarded to the National Reference 
Centre for Mycobacteriology (Win-
nipeg, Manitoba, Canada) for partial 
16S ribosomal RNA gene sequence 
identiﬁ   cation. It corresponded with 
100% sequence identity to the type 
strain of M. heckeshornense. The 
16S rRNA gene sequence analyzed 
for this isolate was 1,314 bp long and 
presented a divergence of 2.6% from 
its closest species, M. xenopi.
Optimal growth temperature and 
extended time to isolation of the initial 
isolate prompted a second incubation 
period of 42 days (total of 84 days) for 
all subsequent cultures. A subsequent 
blood culture was positive at 53 days 
of incubation. If negative after this 
reincubation period, a terminal Ziehl-
Neelsen smear was performed to con-
ﬁ  rm absence of AFB.
Susceptibility testing of the ini-
tial blood and urine isolates was 
performed by using the radiometric 
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broth MIC method (Becton Dickin-
son BACTEC 460 radiometric sys-
tem; Becton Dickinson Microbiology 
Systems) and by microbroth dilution 
method (TREK Diagnostics, Cleve-
land, OH, USA) for isoniazid and 
streptomycin. Susceptibility results 
were as follows: amikacin MIC <2.0 
μg/mL, ciproﬂ  oxacin MIC <1.0 μg/
mL, clarithromycin MIC <16.0μg/
mL, rifabutin MIC <0.12 μg/mL, 
ethambutol MIC <8.0 μg/mL, isoni-
azid MIC 1.0 μg/mL, and streptomy-
cin MIC 8.0 μg/mL (6).
Disseminated disease caused by 
nontuberculous mycobacteria (NTM) 
has been described for HIV-infected 
patients with CD4 counts <50 cells/
mm3. More than 90% of NTM cases 
are caused by M. avium–intracellulare 
complex (MAC) (7). Reports of M. 
heckeshornense infection are limited 
to immunocompetent persons with 
lung disease (1–3), tenosynovitis (4), 
and axillary lymphadenitis (5), attest-
ing to the organism’s virulence.
No criteria exist for diagnosing 
disseminated NTM infection other 
than MAC, which is based on clini-
cal signs and isolation from cultures 
of blood, lymph node, bone mar-
row, or other sterile sites. The most 
common diagnostic method is blood 
culture, positive for >90% of cases 
(7).  M. heckeshornense was con-
sidered the etiologic agent for the 
patient reported here on the basis 
of repeated blood culture isolation, 
clinical signs, and improvement with 
treatment. Concomitant antiretrovi-
ral therapy and immune restoration 
also likely contributed to the patient’s 
improvement.
The incidence of M. heckeshorn-
ense infection may be underestimated 
because of incubation time allowed by 
the BACTEC 9000 series instruments 
at 42 days. The positive cultures for 
this patient were obtained close to or 
after the traditional 42-day period and 
without reincubation may have been 
missed. Piersimoni et al. (8) found 
that most blood cultures for M. xenopi 
were detected with terminal AFB and 
visual growth inspection performed 
after the isolates had been determined 
as negative by conventional means at 
42 days, which suggests a need for 
prolonged incubation.
The optimal treatment for M. 
heckeshornense infection has not been 
established. Its phenotypic and geno-
typic resemblance to M. xenopi sug-
gests that similar treatment may be 
reasonable. Current recommendations 
for treatment for M. xenopi infection 
include isoniazid, rifampin or rifabu-
tin, and ethambutol, with or without an 
initial phase of streptomycin (9). For 
HIV-infected patients, consideration 
should be given to prolonged treat-
ment similar to that for disseminated 
MAC infection, generally >12 months 
and accompanied by a sustained (>6 
months) increase in CD4 counts to 
>100 cells/mm3 (9).
We report disseminated M. hecke-
shornense in an HIV-infected patient, 
documenting the pathogen’s increas-
ing clinical spectrum. Its isolation re-
quires prolonged incubation and may 
be missed by standard mycobacterial 
isolation instruments. 
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Geographic 
Expansion of 
Baylisascaris 
procyonis 
Roundworms, 
Florida, USA
To the Editor:  Baylisascaris 
procyonis roundworms are common 
parasites of raccoons (Procyon lotor) 
in several regions of North America, 
Europe, and Asia. These parasites are 
increasingly recognized as a cause of 
larva migrans in humans, an infection 
that often results in severe neurologic 
sequelae or death. In addition, larva 
migrans has been documented in ≈90 
species of wild and domestic birds 
and mammals. In the United States, B. 
procyonis roundworms are most prev-
alent in the midwestern, northeastern, 
and Paciﬁ   c western states. Numer-
ous surveillance studies have been 
conducted in the southeastern United 
States, and B. procyonis roundworms 
are most common in the mountain-
ous regions of Virginia, Kentucky, 
and West Virginia (1–4). Geographic 
expansion of B. procyonis round-
worms has been recently documented 
in Georgia. In 2002, 22% of raccoons 
sampled in DeKalb County, Georgia, 
a highly urbanized area near Atlanta, 
were positive for the parasite (5), and 
recently, 10% of raccoons sampled in 
Clarke County, Georgia, were positive 
(6). Whether this expansion is due to 
natural spread of the parasite among 
raccoons or to translocations of infect-
ed raccoons into naive areas is unclear. 
We document expansion of B. procyo-
nis roundworms into northwestern and 
southeastern Florida. 
In 2006 and 2007, nine ascarids 
(>3 inches) were collected from the 
feces of an unrecorded number of rac-
coons admitted to a rehabilitation cen-
ter in northern Florida. In September 
2008, December 2009, and June 2010, 
one ascarid each was found in the 
feces of a 4- and a 6-month-old rac-
coon from Leon County, Florida, and 
a 6-month-old raccoon from Wakulla 
County, Florida, after routine treat-
ment with pyrantel pamoate (20 mg/
kg). In July 2010, a juvenile (6-month-
old) raccoon from Broward County, 
Florida, which had been admitted to 
a rehabilitation center, passed several 
ascarids (2 collected for testing) in its 
feces after ivermectin treatment (0.2 
mg/mL) for mange. The 14 ascarids 
were preserved in 70% ethanol, and 
adult males were identiﬁ  ed as Bay-
lisascaris spp. on the basis of their 
morphologic characteristics (perianal 
rough patches). The ascarids were 
subsequently conﬁ  rmed as B. procyo-
nis by sequence analysis of the 5.8S 
rRNA gene or the internal transcribed 
spacer (ITS)-1 and ITS-2 regions 
(7,8). The complete sequences of the 
5.8S rRNA gene and ITS-2 region 
from 2 ascarids from northern Flori-
da and 1 from southern Florida were 
identical to B. procyonis sequences 
(GenBank accession nos. AJ001501 
and AB051231, respectively). ITS-1 
sequences from the 2 ascarids from 
northern and southern Florida were 
99.1% (424/428; AB053230) to 100% 
identical (AJ00745 and ascarids from 
Georgia, Kentucky, and Texas [6]), re-
spectively, to B. procyonis sequences.
Several previous studies did not 
detect  B. procyonis roundworms in 
raccoons or latrine sites in central 
Florida (n = 51 from Glades, High-
lands, Hillsborough, and Orange 
counties), southern Florida (n = 90 
from around Miami and n = 64 fecal 
samples on Key Largo), and numer-
ous counties throughout Florida (n 
= 177) (1,3,9). Historically, B. pro-
cyonis roundworms have been absent 
throughout most of the Southeast, but 
the parasite was recently detected in 
north-central Georgia (5,6). How the 
species became established in Florida 
remains unclear. Establishment could 
have resulted from natural dispersal of 
infected raccoons from B. procyonis–
endemic areas; however, recent exam-
ination of several raccoon populations 
in southern Georgia failed to detect 
such infections (6). Alternatively, the 
parasites could have been introduced 
from the movement of infected rac-
coons, exotic pets (e.g., kinkajou [Po-
tos ﬂ  avus]), or natural wildlife inter-
mediate hosts (1). 
Additionally, because domestic 
dogs can serve as deﬁ  nitive hosts, an 
infected dog from a B. procyonis–en-
demic area may have passed eggs into 
the environment (1). Veterinarians in 
Florida should be aware of this pos-
sible zoonosis and carefully examine 
ascarid eggs detected in fecal speci-
mens because B. procyonis–infected 
dogs often have mixed infections with 
Toxocara canis,  Toxascaris leonina, 
or both, which have morphologically 
similar eggs (1). Physicians, veterinar-
ians, and wildlife biologists in Florida 
should be aware of this serious patho-
gen and the likelihood its range will 
increase, as highlighted by the recent 
detection of B. procyonis roundworms 
in a kinkajou from southern Florida 
(K.P. Kazacos et al., unpub. data).
This study also highlights the 
importance of wildlife rehabilitation 
centers as resources for the study of 
wildlife/zoonotic diseases. Animals 
admitted to rehabilitation centers are 
often ill or injured, which may in-
crease pathogen shedding or transmis-
sion. Additionally, young raccoons are 
likely to be infected with B. procyonis 
roundworms, and kits as young as 3 
months of age can be patent. Numer-
ous fatal B. procyonis larva migrans 
infections have occurred among ani-
mals in rehabilitation centers and zoo-
logical parks. These infections were 
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